Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 13/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
| ▸ | DRD5 | P21918 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1509710 | 1.00 | HRH3 (0.45) | HRH3KCNH2CYP3A4CYP2C9RAB9A | |
| SCHEMBL2720561 | 0.91 | HRH3 (0.51) | HRH3KCNH2CYP3A4CYP2C9RAB9A | |
| SCHEMBL2721397 | 0.91 | HRH3 (0.51) | HRH3KCNH2CYP3A4CYP2C9RAB9A | |
| SCHEMBL2719574 | 0.91 | HRH3 (0.51) | HRH3KCNH2CYP3A4CYP2C9RAB9A | |
| SCHEMBL2717763 | 0.89 | HRH3 (0.52) | HRH3KCNH2CYP3A4CYP2C9RAB9A | |
| SCHEMBL1531796 | 0.87 | ESR2 (0.51) | KCNH2CYP3A4CYP2C9 | |
| SCHEMBL1531798 | 0.87 | ESR2 (0.51) | KCNH2CYP3A4CYP2C9 | |
| SCHEMBL12216962 | 0.86 | HRH3 (0.45) | HRH3KCNH2CYP3A4CYP2C9RAB9A | |
| SCHEMBL1509691 | 0.85 | HRH3 (0.60) | HRH3KCNH2CYP3A4CYP2C9RAB9A | |
| SCHEMBL1509692 | 0.85 | HRH3 (0.60) | HRH3KCNH2CYP3A4CYP2C9RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8039064-B2 | Compound, polymerizable liquid crystal composition, optical element and optical information writing/reading device | ASAHI GLASS COMPANY, LIMITED (JP) | 2011-10-18 | — | — | US | disclosed |
| US-20110063966-A1 | COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, OPTICAL ELEMENT AND OPTICAL INFORMATION WRITING/READING DEVICE | ASAHI GLASS COMPANY, LIMITED (JP) | 2011-03-17 | — | — | US | disclosed |
| EP-2295396-A1 | COMPOUND, POLYMERIZABLE LIQUID CRYSTALLINE COMPOSITION, OPTICAL ELEMENT, AND OPTICAL INFORMATION RECORDING/REPRODUCTION DEVICE | Asahi Glass Company, Limited (JP) | 2011-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110063966-A1 | COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, OPTICAL ELEMENT AND OPTICAL INFORMATION WRITING/READING DEVICE | CRY2, NOXO1, CIT | HRH3 219/4885KCNH2 562/4885CYP3A4 536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.